Figure 1From: Overdiagnosis in breast cancer screening: the importance of length of observation period and lead timeExpected cumulative incidence over ages 50 to 79 in a cohort of women of age 50 at the start, with and without 2-yearly screening from age 50 to 69.Back to article page